日本性生活网站,美女视频免费观看的网站,巨乳软件早川瑞希,午夜婷婷一区,亚洲精品国产网红主播在线,亚洲欧美日韩综合在线一区

今天是2024年11月17日 星期日,歡迎光臨本站 上海研生實(shí)業(yè)有限公司 網(wǎng)址: jym5566.cn

一抗

轉(zhuǎn)錄因子AP2α+β抗體

文字:[大][中][小] 2017-5-4    瀏覽次數(shù):961    

                                                       轉(zhuǎn)錄因子AP2α+β抗體                                                                                                                                                
英文名稱  Anti-AP2 alpha + beta 
中文名稱  轉(zhuǎn)錄因子AP2α+β抗體 
別    名  Activating enhancer binding protein 2 alpha; Activating enhancer binding protein 2 beta; AP2TF; TFAP2; TFAP2A; TFAP2B; Transcription factor AP2 alpha; Transcription factor AP2 beta; AP2A_HUMAN; AP2B_HUMAN. 

詳細(xì)介紹:


濃    度  1mg/1ml 
規(guī) 格  0.2ml/200μg  
抗體來源  Rabbit  
克隆類型  polyclonal 
交叉反應(yīng)  Human, Mouse, Rat, Chicken, Dog, Pig, Horse, Rabbit, Sheep  
產(chǎn)品類型  一抗    
研究領(lǐng)域  腫瘤 發(fā)育生物學(xué) 轉(zhuǎn)錄調(diào)節(jié)因子 結(jié)合蛋白 細(xì)胞分化 表觀遺傳學(xué)  
蛋白分子量  predicted molecular weight: 48kDa 
性    狀  Lyophilized or Liquid 
免 疫 原  KLH conjugated synthetic peptide derived from human AP2 alpha + beta 
亞    型  IgG 
純化方法  affinity purified by Protein A 
儲 存 液  Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4 
產(chǎn)品應(yīng)用   WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500 
(石蠟切片需做抗原修復(fù)) 
 not yet tested in other applications.
 optimal dilutions/concentrations should be determined by the end user.  
保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

相關(guān)資料:


產(chǎn)品介紹 The AP2 proteins are normally expressed in ectodermally derived vertebrate tissues where they are necessary for normal growth and development. The factors have also been implicated in the control of cell proliferation, viral transformation, and oncogenesis. AP2 seems to play in important role in human breast cancer. AP2 alpha is the only AP2 protein required for early morphogenesis of the lens vesicle. AP2 beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia.
Function : Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region. 
Subunit : Binds DNA as a dimer. Can form homodimers or heterodimers with other AP-2 family members. Interacts with WWOX. Interacts with CITED4. Interacts with UBE2I. Interacts with RALBP1 in a complex also containing EPN1 and NUMB during interphase and mitosis. Interacts with KCTD1; this interaction represses transcription activation. Interacts (via C-terminus) with CITED2 (via C-terminus); the interaction stimulates TFAP2A-transcriptional activation. Interacts (via N-terminus) with EP300 (via N-terminus); the interaction requires CITED2. 
Subcellular Location : Nuclear.
Post-translational modifications : Sumoylated on Lys-10; which inhibits transcriptional activity (Probable). 
DISEASE : Defects in TFAP2A are the cause of branchiooculofacial syndrome (BOFS) [MIM:113620]; also known as branchial clefts with characteristic facies, growth retardation, imperforate nasolacrimal duct, and premature aging or lip pseudocleft-hemangiomatous branchial cyst syndrome. BOFS is a rare autosomal dominant cleft palate craniofacial disorder with variable expressivity. The major features include cutaneous anomalies, ocular anomalies, characteristic facial appearance (malformed pinnae, oral clefts), and, less commonly, renal and ectodermal (dental and hair) anomalies.
Similarity : Belongs to the AP-2 family.
Database links : UniProtKB/Swiss-Prot: P05549.1 UniProtKB/Swiss-Prot: Q92481.2 

返回上一步
打印此頁
[向上]

網(wǎng)站首頁

公司介紹

產(chǎn)品中心

技術(shù)服務(wù)

技術(shù)文獻(xiàn)

在線留言

聯(lián)系我們

在線客服

售前咨詢

售后服務(wù)

咨詢電話:
021-59989018

請掃描二維碼
打開手機(jī)站